• 1. Effects of N-alkylation and NN-dialkylation on the pK a of anilinium and nitroanilinium ions
  John W. Eastes,Mary H. Aldridge,Mortimer J. Kamlet a of anilinium and nitroanilinium ions. John W. Eastes Mary H. Aldridge Mortimer J. Kamlet J. Chem. Soc. B 1969 922
• 2. Solvent/metal-free benzimidazolium-based carboxyl-functionalized porphyrin photocatalysts for the room-temperature alkylation of amines under the irradiation of visible light
  Subodh Uttamrao Raut,Kamlesh Rudreshwar Balinge,Shubham Avinash Deshmukh,Shital Haribhau Barange,Bhairav Chandroday Mataghare,Pundlik Rambhau Bhagat Catal. Sci. Technol. 2022 12 5917
• 3. 950. Phosphorescence and fluorescence of some aromatic nitro-amines
  R. Foster,D. Ll. Hammick,G. M. Hood,A. C. E. Sanders J. Chem. Soc. 1956 4865
• 4. Viscosity-dependent fluorescence and low-temperature photochemistry of mesoionic 4-phenyl-1,3,2-oxathiazolylium-5-olate
  Niels Harrit,Arne Holm,Ian R. Dunkin,Martyn Poliakoff,James J. Turner J. Chem. Soc. Perkin Trans. 2 1987 1227

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Professional Introduction to N-Ethyl-4-nitroaniline (CAS No. 3665-80-3)

N-Ethyl-4-nitroaniline, a compound with the chemical formula C?H?N?O? and CAS number 3665-80-3, is a significant intermediate in the field of organic synthesis and pharmaceutical research. This compound, characterized by its nitro and ethyl substituents on an aniline backbone, has garnered attention due to its versatile applications in various chemical transformations and its potential role in the development of novel therapeutic agents.

The structural motif of N-Ethyl-4-nitroaniline consists of a benzene ring substituted with a nitro group at the 4-position and an ethylamine moiety at the 1-position. This specific arrangement imparts unique reactivity, making it a valuable building block for synthesizing more complex molecules. The nitro group, known for its electron-withdrawing properties, influences the electronic distribution of the aromatic ring, enhancing its participation in electrophilic aromatic substitution reactions. Conversely, the ethyl group introduces steric hindrance and can affect the compound's solubility and metabolic stability.

In recent years, N-Ethyl-4-nitroaniline has been explored in the context of medicinal chemistry for its potential as a precursor in the synthesis of bioactive molecules. Research has highlighted its utility in constructing heterocyclic scaffolds, which are prevalent in many pharmacologically active compounds. For instance, studies have demonstrated its role in the preparation of derivatives that exhibit antimicrobial and anti-inflammatory properties. The nitro group can be further functionalized through reduction to an amine or through diazotization followed by coupling reactions, opening up multiple avenues for structural diversification.

One of the most compelling aspects of N-Ethyl-4-nitroaniline is its involvement in catalytic processes that enable efficient transformations. The compound has been utilized as a ligand or intermediate in transition metal-catalyzed reactions, such as cross-coupling and hydrogenation processes. These reactions are pivotal in constructing carbon-carbon bonds, a fundamental requirement for many drug molecules. The ability to manipulate these bonds with high precision underscores the importance of N-Ethyl-4-nitroaniline in synthetic chemistry.

Advances in computational chemistry have also contributed to a deeper understanding of N-Ethyl-4-nitroaniline's reactivity. Molecular modeling studies have revealed insights into how the nitro and ethyl groups interact with various catalysts and substrates, providing a theoretical framework for optimizing synthetic routes. These computational approaches are increasingly being integrated with experimental work to accelerate the discovery and development of new pharmaceuticals.

The pharmaceutical industry has shown particular interest in N-Ethyl-4-nitroaniline due to its potential as a scaffold for drug discovery. Researchers have synthesized analogs of this compound that exhibit improved pharmacokinetic profiles or enhanced binding affinity to target proteins. For example, modifications to the nitro group have led to derivatives with altered electronic properties, which can fine-tune their interaction with biological targets. Such modifications are crucial for developing drugs that are both effective and well-tolerated by patients.

In addition to its pharmaceutical applications, N-Ethyl-4-nitroaniline finds utility in materials science. Its ability to undergo selective functionalization makes it a valuable precursor for designing advanced materials with tailored properties. For instance, researchers have explored its use in creating conductive polymers or organic semiconductors, where precise control over molecular architecture is essential for optimal performance.

The synthesis of N-Ethyl-4-nitroaniline itself is another area of active research. Recent developments have focused on developing greener and more efficient synthetic methodologies that minimize waste and reduce environmental impact. Catalytic processes using renewable feedstocks or biocatalysts are being investigated as alternatives to traditional synthetic routes. These innovations align with broader efforts to promote sustainable chemistry practices across the industry.

Looking ahead, the future prospects for N-Ethyl-4-nitroaniline appear promising, driven by ongoing advancements in synthetic chemistry and drug discovery technologies. As our understanding of molecular interactions deepens, new applications for this compound are likely to emerge. Collaborative efforts between academia and industry will be crucial in translating these findings into tangible benefits for society.

• 58259-34-0(N-Butyl-4-nitroaniline)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)